AGP Executive Report
Last update: 3 hours agoAI in labs: Nigeria’s Medical Laboratory Science Council plans to fold AI, biosecurity and bioinformatics into the Bachelor of Medical Laboratory Science curriculum. Pharma deal: Russia’s Pharmasynthesis buys 70% of dialysis-solution maker Rester to modernize production and expand domestic peritoneal dialysis supply. Access to complex therapies: Spain’s health system approves a protocol to coordinate cross-region access to high-cost medicines (starting with 66 therapies) to cut bureaucracy and standardize rules. Alcohol medicine crackdown: India withdraws licensing exemptions for medicinal formulations with over 12% ethyl alcohol (above 30 ml), moving them to prescription-only sale with tighter record-keeping. Medicaid fight: A coalition of 25 states sues over new Medicaid work requirements, arguing they could strip coverage from eligible low-income adults. Heat and meds: UK pharmacists warn that common drugs can worsen heat risks; a list includes diuretics, blood pressure meds, antidepressants and diabetes treatments. Medical innovation: Harvard reports a silicon chip that can write multiple DNA sequences using electricity and water-based enzymes, aiming to make custom genetic material cleaner and faster.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
